SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-058436
Filing Date
2020-05-08
Accepted
2020-05-08 09:08:13
Documents
15
Period of Report
2020-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2019009-2_8k.htm   iXBRL 8-K 31686
2 EXHIBIT 5.1 tm2019009d2_ex5-1.htm EX-5.1 11563
3 EXHIBIT 10.1 tm2019009d2_ex10-1.htm EX-10.1 262710
4 GRAPHIC tm2019009d2_ex5-1img001.jpg GRAPHIC 12973
  Complete submission text file 0001104659-20-058436.txt   565430

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20200508.xsd EX-101.SCH 3195
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20200508_lab.xml EX-101.LAB 34591
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20200508_pre.xml EX-101.PRE 22716
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2019009-2_8k_htm.xml XML 3494
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 20858949
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences